Adeniji J A, Oragwa A O, George U E, Ibok U I, Faleye T O C, Adewumi M O
Department of Virology, College of Medicine, University of Ibadan, Ibadan, Oyo State, Nigeria.
WHO National Polio Laboratory, University of Ibadan, Ibadan, Oyo State, Nigeria.
Arch Virol. 2017 Oct;162(10):3089-3101. doi: 10.1007/s00705-017-3466-2. Epub 2017 Jul 10.
Recently, a reverse transcriptase semi-nested polymerase chain reaction (RT-snPCR) assay was recommended by the WHO for direct detection of enteroviruses in clinical specimens. In this study, we use this assay and a modification thereof to screen acute flaccid paralysis (AFP) samples that had previously tested negative for enteroviruses by the RD-L20B algorithm. Thirty paired stool suspensions collected in 2015 as part of the national AFP surveillance program in different states of Nigeria were analyzed in this study. The samples had previously tested negative for enteroviruses in the polio laboratory in accordance with the WHO-recommended RD-L20B-cell-culture-based algorithm. Two samples that had previously been found to contain enteroviruses were included as positive controls. All samples were subjected to RNA extraction, the RT-snPCR assay and a modified version of the RT-snPCR. All amplicons were sequenced, and enteroviruses were identified using the enterovirus genotyping tool and phylogenetic analysis. Amplicons were recovered from the two controls and 50% (15/30) of the samples screened. Fourteen were successfully typed, of which, 7.1% (1/14), 21.4% (3/14), 64.3% (9/14) and 7.1% (1/14) were enterovirus (EV) -A, EV-B, EV-C and a mixture of EV-B and C (EV-C99 and E25), respectively. The two controls were identified as EV-C99 and coxsackievirus (CV) -A1, both of which belong to the species Enterovirus C. In one sample, poliovirus serotype 2 was detected and found to have the VP1 143 variation and was therefore identified as a vaccine strain. The results of this study showed that significant proportion of enterovirus infections (including some with Sabin PV2) are being missed by the RD-L20B-cell-culture-based algorithm, thus highlighting the value of the RT-snPCR assay and its modifications. The circulation and preponderance of EV-C in Nigeria was also confirmed.
最近,世界卫生组织推荐了一种逆转录酶半巢式聚合酶链反应(RT-snPCR)检测方法,用于直接检测临床标本中的肠道病毒。在本研究中,我们使用该检测方法及其改进方法,对先前通过RD-L20B算法检测肠道病毒呈阴性的急性弛缓性麻痹(AFP)样本进行筛查。本研究分析了2015年作为尼日利亚不同州国家AFP监测计划的一部分收集的30对粪便悬液。这些样本先前按照世界卫生组织推荐的基于RD-L20B细胞培养的算法,在脊髓灰质炎实验室检测肠道病毒呈阴性。包括两个先前发现含有肠道病毒的样本作为阳性对照。所有样本均进行RNA提取、RT-snPCR检测及RT-snPCR的改进版本检测。对所有扩增子进行测序,并使用肠道病毒基因分型工具和系统发育分析鉴定肠道病毒。从两个对照和50%(15/30)的筛查样本中回收扩增子。14个成功分型,其中分别有7.1%(1/14)、21.4%(3/14)、64.3%(9/14)和7.1%(1/14)为肠道病毒(EV)-A、EV-B、EV-C以及EV-B和C的混合物(EV-C99和E25)。两个对照分别鉴定为EV-C99和柯萨奇病毒(CV)-A1,它们均属于肠道病毒C种。在一个样本中检测到脊髓灰质炎2型病毒,发现其VP1 143位有变异,因此鉴定为疫苗株。本研究结果表明,基于RD-L20B细胞培养的算法遗漏了相当比例的肠道病毒感染(包括一些含有Sabin PV2的感染),从而突出了RT-snPCR检测方法及其改进方法的价值。尼日利亚EV-C的传播和优势地位也得到了证实。